Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · IEX Real-Time Price · USD
1.870
+0.240 (14.72%)
At close: Apr 22, 2024, 4:00 PM
1.780
-0.090 (-4.81%)
After-hours: Apr 22, 2024, 7:37 PM EDT
Carisma Therapeutics Stock Forecast
CARM's stock price has decreased by -54.94% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 5 analysts with 12-month price forecasts for CARM stock have an average target of 9.40, with a low estimate of 6.00 and a high estimate of 12. The average target predicts an increase of 402.67% from the current stock price of 1.87.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CARM stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +220.86% | Apr 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +381.28% | Apr 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +488.24% | Nov 29, 2023 |
| Capital One | Capital One | Buy Initiates $10 | Buy | Initiates | $10 | +434.76% | Oct 3, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +488.24% | Sep 6, 2023 |
Financial Forecast
Revenue This Year
16.49M
from 14.92M
Increased by 10.52%
Revenue Next Year
17.64M
from 16.49M
Increased by 6.96%
EPS This Year
-1.63
from -2.59
EPS Next Year
-1.51
from -1.63
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 18.0M | 37.8M | 71.4M | 109.2M | 169.4M |
| Avg | 16.5M | 17.6M | 34.7M | 53.0M | 88.5M |
| Low | 15.2M | n/a | n/a | n/a | 12.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 20.8% | 129.3% | 304.9% | 214.9% | 219.3% |
| Avg | 10.5% | 7.0% | 96.6% | 52.9% | 66.8% |
| Low | 1.8% | - | - | - | -77.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.13 | -1.00 | -0.78 | 0.23 | 1.17 |
| Avg | -1.63 | -1.51 | -1.45 | -1.03 | -0.47 |
| Low | -2.01 | -2.05 | -2.07 | -2.20 | -2.00 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.